-
EP3801461
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3801461
| EP3801461 - METHOD AND FORMULATION FOR IMPROVING ROFLUMILAST SKIN PENETRATION LAG TIME [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 19.09.2024 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 12.03.2021 | ||
| Former | The international publication has been made Status updated on 14.12.2019 | ||
| Former | unknown Status updated on 08.11.2019 | Most recent event Tooltip | 29.05.2025 | New entry: Renewal fee paid | Applicant(s) | For all designated states Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, No. 300 Westlake Village, CA 91361 / US | [N/P] |
| Former [2021/24] | For all designated states Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 / US | ||
| Former [2021/15] | For all designated states Arcutis, Inc. 70 Willow Road Menlo Park CA 94025 / US | Inventor(s) | 01 /
OSBORNE, David, W. 4215 Creekside Court Fort Collins, CO 80525 / US | [2021/15] | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [N/P] |
| Former [2021/15] | Weiss, Wolfgang Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB Postfach 860 820 81635 München / DE | Application number, filing date | 19795698.0 | 30.05.2019 | [2021/15] | WO2019US34640 | Priority number, date | US201862680203P | 04.06.2018 Original published format: US 201862680203 P | US201862742644P | 08.10.2018 Original published format: US 201862742644 P | [2021/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019236374 | Date: | 12.12.2019 | Language: | EN | [2019/50] | Type: | A2 Application without search report | No.: | EP3801461 | Date: | 14.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.12.2019 takes the place of the publication of the European patent application. | [2021/15] | Search report(s) | International search report - published on: | EP | 16.01.2020 | Classification | IPC: | A61K9/00, A61K9/06, A61K31/44, A61K47/10, A61K47/14 | [2021/15] | CPC: |
A61K9/06 (EP,CN,IL,KR,US);
A61K9/0014 (EP,CN,IL,KR,US);
A61K31/44 (EP,CN,IL,KR,US);
A61K31/122 (IL,US);
A61K31/17 (IL,US);
A61K31/194 (IL,US);
A61K31/366 (IL,US);
A61K31/52 (IL,US);
A61K31/5377 (IL,US);
A61K31/573 (IL,US);
A61K31/60 (IL,US);
A61K45/06 (EP,IL,KR,US);
A61K47/10 (EP,CN,IL,KR,US);
A61K47/14 (EP,CN,IL,KR,US);
A61K47/24 (CN,IL,KR,US);
A61K47/6903 (IL,US);
A61K9/107 (CN,IL,KR,US);
A61K9/122 (CN,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/15] | Title | German: | VERFAHREN UND FORMULIERUNG ZUR VERBESSERUNG DER HAUTDURCHDRINGUNGSVERZÖGERUNGSZEIT VON ROFLUMILAST | [2021/15] | English: | METHOD AND FORMULATION FOR IMPROVING ROFLUMILAST SKIN PENETRATION LAG TIME | [2021/15] | French: | MÉTHODE ET FORMULATION POUR AMÉLIORER LE TEMPS DE LATENCE DE PÉNÉTRATION DE LA PEAU DU ROFLUMILAST | [2021/15] | Entry into regional phase | 18.12.2020 | National basic fee paid | 18.12.2020 | Designation fee(s) paid | 18.12.2020 | Examination fee paid | Examination procedure | 18.12.2020 | Examination requested [2021/15] | 18.12.2020 | Date on which the examining division has become responsible | 14.06.2021 | Amendment by applicant (claims and/or description) | 23.09.2024 | Despatch of a communication from the examining division (Time limit: M04) | 11.12.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 18.12.2020 | Renewal fee patent year 03 | 27.05.2022 | Renewal fee patent year 04 | 12.05.2023 | Renewal fee patent year 05 | 30.05.2024 | Renewal fee patent year 06 | 29.05.2025 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XP] WO2019060379 (ARCUTIS INC et al.) | [XI] US9907788 (OSBORNE DAVID W et al.) | by applicant | US5712298 | US201314075035 | M.S. ROBERTSK.A. WALTERS: "Dermal Absorption and toxicity Assessment", 1998, MARCEL DEKKER, article "Prediction-Simple Risk Models and Overview of Dermal Risk Assessment", pages: 203 - 229 | JD BOSMM MEINARDI, EXP DERMATOL., vol. 9, no. 3, June 2000 (2000-06-01), pages 165 - 9 | D.W. OSBORNEW.J. LAMBERT: "Prodrugs for Dermal Delivery", 1992, MARCEL DEKKER, pages: 163 - 178 | N. LIX. WUW. JIAM.C. ZHANGF. TANJ ZHANG, DRUG DEV INDUST PHARM, vol. 38, no. 8, pages 985 - 994 | D.W. OSBORNEJ.J. HENKE, PHARMACEUTICAL TECHNOLOGY, vol. 21, no. 11, 1997, pages 58 - 66 |